A Kaiser Permanente study published by NEJM Catalyst Innovations in Care Delivery provides real-world data on a new approach to cervical cancer screening: giving patients the option to skip the traditional pelvic exam and collect their own vaginal samples to test for the human papillomavirus (HPV)—the cause of nearly all cervical cancers. The study is the first within a U.S. health care organization to demonstrate the potential of large-scale, population-based HPV self-collection—both via mail and in clinics—to improve access to preventive care and overcome barriers to traditional screenings.
Continue Reading this article here
